The state assessed $344 million in penalties against Ethicon, a subsidiary of Johnson & Johnson, in January 2020, after ruling the company made “misleading and potentially harmful statements” in advertisements and instructional brochures for nearly two decades.
A district court of appeals later ruled $42 million of the penalties were unjustified due to lack of evidence pertaining to statements made by sales representatives.
Ryan Carbain, a spokesperson for Johnson & Johnson, told The San Francisco Chronicle the company plans to appeal to the state Supreme Court.
“Ethicon responsibly communicated the risks and benefits of its transvaginal mesh products to doctors and patients and in full compliance with U.S. Food and Drug Administration laws,” Mr. Carbain said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
